Prohibit short-selling on companies developing life-saving treatment

Prohibit short-selling on companies developing life-saving treatment — 138 signatures. Status: closed.

Petition background

We the undersigned, call on Parliament to ban the practice of short-selling publicly traded British companies actively engaged in the research and development of treatments for cancer and other life-threatening disorders.

Additional details

The British biotech sector plays a critical role in advancing healthcare, with companies often investing significant time, capital and intellectual resources into developing novel and transformative treatments for conditions like acute myeloid/lymphoblastic leukaemias and other cancers that have been historically hard to treat. We believe that short-selling damages their ability to complete vital research in the area.

View this petition on the official UK Parliament website

Other UK Parliament petitions

Hold a referendum to bring the water industry into public ownership — 210,924 signatures
Legislate to ban FPNs and prosecutions related to school attendance — 135,053 signatures
Hold a UK-wide briefing on climate and nature risks — 123,819 signatures
Change surrogacy law to recognise intended parents from birth — 113,200 signatures
Support the Ceramics Industry and protect British manufacturing jobs and skills — 111,044 signatures
Remove sentence reductions for guilty pleas in controlling and coercive cases — 105,588 signatures
Fund NHS access to Omaveloxolone for patients with Friedreich's Ataxia — 102,394 signatures
Raise the personal tax allowance to £18,000 — 72,554 signatures

Browse UK petitions

UK Petition Tracker home